Clinical Trial

Efficacy and Safety of Tocilizumab in the Treatment of Generalized Myasthenia Gravis

Study acronym: tMG
Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated May 1, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
Randomized, double-blind, placebo-controlled, parallel-group study with optional open-label extension.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2021-09-23; most recent amendment 2025-04-28.
Status change: Not Yet Recruiting → Recruiting 2022-09-15
Trial Details
NCT Number NCT05067348
Lead Sponsor Tang-Du Hospital
Conditions Myasthenia Gravis, Generalized
Enrollment 64 participants
Start Date 2022-07-21
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-03-30 (estimated)
Updated on ClinicalTrials.gov 2025-05-01